| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
40,250,000 |
| Market
Cap: |
56.75(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.37 - $9.49 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Sesen Bio is a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer. Co.'s main product candidate Vicinium (VB4-845), is a locally-administered targeted fusion protein composed of an anti-epithelial cell adhesion molecule (EpCAM) antibody fragment tethered to a truncated form of Pseudomonas exotoxin A for the treatment of non-muscle invasive carcinoma in situ of the bladder in patients previously treated with adequate or less than adequate bacillus Calmette-Guerin. Co.'s lead systemically-administered product candidate, VB6-845d, is being developed as a treatment for multiple types of EpCAM-positive solid tumors.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
1,428,721 |
| Total Sell Value |
$0 |
$0 |
$0 |
$838,716 |
| Total People Sold |
0 |
0 |
0 |
5 |
| Total Sell Transactions |
0 |
0 |
0 |
10 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Honig Peter |
Director |
– • – |
2022-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
40,000 |
|
- |
|
| Bourdow Carrie L. |
Director |
– • – |
2022-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
40,000 |
|
- |
|
| Sullivan Mark |
General Counsel & Secretary |
• – – |
2022-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
339,525 |
339,525 |
|
- |
|
| Macdonald Glen C |
Chief Technology Officer |
• – – |
2022-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
308,925 |
308,925 |
|
- |
|
| Cannell Thomas R |
President and CEO |
• • – |
2022-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
606,800 |
606,800 |
|
- |
|
| Ryu Elly |
Principal Accounting Officer |
• – – |
2022-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
86,300 |
86,300 |
|
- |
|
| Forbes Monica |
Chief Financial Officer |
• – – |
2022-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
542,250 |
542,250 |
|
- |
|
| Ryu Elly |
Principal Accounting Officer |
• – – |
2021-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
115,000 |
126,696 |
|
- |
|
| Ryu Elly |
Principal Accounting OfficerOf |
• – – |
2021-04-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
11,696 |
|
-63% |
|
| Anderson Kirstin |
Principal Accounting OfficerOf |
• – – |
2019-08-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
32,228 |
|
- |
|
| Mccabe John J |
Chief Financial Officer |
• – – |
2017-02-14 |
4 |
S |
$2.10 |
$2,938 |
D/D |
(1,399) |
5,930 |
|
- |
|
| Celniker Abbie |
Director |
– • – |
2016-09-28 |
4 |
S |
$3.00 |
$30,093 |
D/D |
(10,031) |
409,915 |
|
- |
|
| Kania Edwin M Jr |
10% Owner |
– – • |
2016-09-23 |
4 |
S |
$3.10 |
$208,856 |
D/D |
(67,071) |
106,787 |
|
- |
|
| Kania Edwin M Jr |
10% Owner |
– – • |
2016-09-22 |
4 |
S |
$3.17 |
$1,194,442 |
D/D |
(376,351) |
120,198 |
|
- |
|
| Kania Edwin M Jr |
10% Owner |
– – • |
2016-09-21 |
4 |
S |
$3.75 |
$1,210,211 |
D/D |
(322,723) |
195,451 |
|
- |
|
| Clairmark Investments Ltd. |
10% Owner |
– – • |
2016-09-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,582,328 |
|
- |
|
| Dan Leslie |
Director |
– • • |
2016-09-20 |
4 |
A |
$0.00 |
$0 |
I/I |
3,582,328 |
3,582,328 |
|
- |
|
| Hurly Stephen A |
President and CEO |
• • – |
2016-09-20 |
4 |
A |
$0.00 |
$0 |
D/D |
398,031 |
398,031 |
|
- |
|
| Kania Edwin M Jr |
10% Owner |
– – • |
2016-09-20 |
4 |
S |
$3.39 |
$182,779 |
D/D |
(53,917) |
259,960 |
|
- |
|
| Kania Edwin M Jr |
10% Owner |
– – • |
2016-09-19 |
4 |
S |
$3.31 |
$32,107 |
D/D |
(9,700) |
270,738 |
|
- |
|
| Kania Edwin M Jr |
10% Owner |
– – • |
2016-09-07 |
4 |
S |
$4.51 |
$422,709 |
D/D |
(93,727) |
282,015 |
|
- |
|
| Kania Edwin M Jr |
10% Owner |
– – • |
2016-09-06 |
4 |
S |
$4.63 |
$165,615 |
D/D |
(35,770) |
290,160 |
|
- |
|
| Mccabe John J |
Chief Financial Officer |
• – – |
2016-08-15 |
4 |
S |
$4.80 |
$5,616 |
D/D |
(1,170) |
7,329 |
|
- |
|
| Tubridy Karen L |
Chief Development Officer |
• – – |
2016-06-27 |
4 |
S |
$2.08 |
$9,094 |
D/D |
(4,372) |
32,753 |
|
- |
|
| Celniker Abbie |
President and CEO |
• • – |
2016-06-27 |
4 |
S |
$2.08 |
$20,860 |
D/D |
(10,029) |
419,946 |
|
- |
|
95 Records found
|
|
Page 2 of 4 |
|
|
0.04 (2.92%) 
